Discussion: Prenatal exposure to anti-D immune globulin and autism risk by Croen et al

被引：0

作者：

DeFranco, Emily ^{[1
]}

Gross, Gilad ^{[1
]}

Shanks, Anthony ^{[1
]}

Johnson, Traci ^{[1
]}

Shen, Tammy ^{[1
]}

机构：

[1] Washington Univ, Sch Med, Dept Obstet & Gynecol, Div Maternal Fetal Med, St Louis, MO 63110 USA

来源：

AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY | 2008年 / 199卷 / 03期

关键词：

D O I：

10.1016/j.ajog.2008.07.026

中图分类号：

R71 [妇产科学];

学科分类号：

100211 ;

摘要：

引用

页码：E1 / E4

页数：4

共 50 条

[21] Anti-D Production Despite Large Volume Rhd Immune Globulin: A Case Study
Hayden, Charlotte
Sherbeck, John
TRANSFUSION, 2022, 62 : 229A - 229A
[22] Subcutaneous anti-d globulin application is a safe treatment option of immune thrombocytopenia in children
Monika M. Trebo
Eva Frey
Helmut Gadner
Milen Minkov
Annals of Hematology, 2010, 89 : 415 - 418
[23] Severe Refractory Thrombocytopenia, Dengue Hemorrhagic Fever, and Intravenous Anti-D Immune Globulin
Wiwanitkit, Viroj
PEDIATRIC HEMATOLOGY AND ONCOLOGY, 2012, 29 (02) : 206 - 207
[24] Trends in anti-D immune globulin for childhood immune thrombocytopenia: Usage, response rates, and adverse effects
Long, Michelle
Kalish, Leslie A.
Neufeld, Ellis J.
Grace, Rachael F.
AMERICAN JOURNAL OF HEMATOLOGY, 2012, 87 (03) : 315 - 317
[25] Subcutaneous anti-d globulin application is a safe treatment option of immune thrombocytopenia in children
Trebo, Monika M.
Frey, Eva
Gadner, Helmut
Minkov, Milen
ANNALS OF HEMATOLOGY, 2010, 89 (04) : 415 - 418
[26] Cost of treating patients with immune thrombocytopenic purpura with anti-D immune globulin and intravenous immune globulin: a retrospective database analysis of outpatient claims
Bonnet, P. O.
Dobler, D.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2009, 7 : 557 - 557
[27] Cost-minimization analysis of anti-D immune globulin versus intravenous immune globulin for the initial treatment of immune thrombocytopenic purpura.
Wetzel, David A.
Tarantino, Michael D.
BLOOD, 2006, 108 (11) : 943A - 943A
[28] Comparison between IV immune globulin (IVIG) and anti-D globulin for treatment of immune thrombocytopenia: a randomized open-label study
Eghbali, Aziz
Azadmanesh, Peyman
Bagheri, Bahador
Taherahmadi, Hasan
Sedeh, Bahman Sadeghi
FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2016, 30 (04) : 385 - 389
[29] RHD zygosity predicts degree of platelet response to anti-D immune globulin treatment in children with immune thrombocytopenia
Despotovic, Jenny M.
McGann, Patrick T.
Smeltzer, Matthew
Aygun, Banu
Ware, Russell E.
PEDIATRIC BLOOD & CANCER, 2013, 60 (09) : E106 - E108
[30] Clinical outcomes after hepatitis C infection from contaminated anti-D immune globulin
Kenny-Walsh, E
NEW ENGLAND JOURNAL OF MEDICINE, 1999, 340 (16): : 1228 - 1233

← 1 2 3 4 5 →